Assessing the Burden of Osteoarthritis in Africa and the Middle East: A Rapid Evidence Assessment
Jamal Al Saleh,Hani Almoallim,Bassel Elzorkany,Ali Al Belooshi,Omar Batouk,Mohamed Fathy,Nora Vainstein,Abdullah M Kaki
DOI: https://doi.org/10.2147/OARRR.S390778
2023-03-16
Open Access Rheumatology: Research and Reviews
Abstract:Jamal Al Saleh, 1 Hani Almoallim, 2 Bassel Elzorkany, 3 Ali Al Belooshi, 4 Omar Batouk, 5 Mohamed Fathy, 6 Nora Vainstein, 7 Abdullah M Kaki 8 1 Department of Rheumatology, Dubai Hospital, Dubai Health Authority, Dubai, United Arab Emirates; 2 Department of Medicine, Medical College, Umm Al-Qura University, Makkah, Saudi Arabia; 3 Rheumatology Department, Cairo University, Cairo, Egypt; 4 Mediclinic City Hospital, Department of Surgery, UAE University, Dubai, United Arab Emirates; 5 King Saud bin Abdulaziz University for Health Sciences, National Guard Health Affairs, Jeddah, Saudi Arabia; 6 Pfizer, Dubai, United Arab Emirates; 7 Pfizer, Buenos Aires, Argentina; 8 Department of Anesthesia and Critical Care, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia Correspondence: Abdullah M Kaki, MD, FRCPC, Professor of Anesthesiology and Pain Medicine, Faculty of Medicine, King Abdulaziz University, PO Box 2907, Jeddah, 21461, Saudi Arabia, Tel/Fax +966126408335, Email ; Introduction/Objectives: This rapid evidence assessment (REA) was conducted to assess the burden of weight-bearing joint osteoarthritis in the developing countries of Africa and the Middle East. Methods: Our REA methodology used a standardized search strategy to identify observational studies, published between January 1, 2010, and April 23, 2020, reporting on outcomes pertaining to the epidemiology and humanistic or economic burden of weight-bearing osteoarthritis. Relevant data from the included studies were used for qualitative analysis. Results: Among the 20 publications reporting on knee osteoarthritis in 10 countries in Africa and the Middle East, 2 also reported on hip, and 1 on foot osteoarthritis. Prevalence of symptomatic/radiographic knee OA was 9– 14% among rheumatology outpatients and 31– 34% among those with mixed etiology osteoarthritis. Prevalence of knee OA diagnosed by magnetic resonance imaging was 70% among patients ≥ 40 years of age attending a hospital in Saudi Arabia. Quality-of-life outcomes were reported in 16 publications and suggested a substantial humanistic burden of osteoarthritis, including worse pain, function, and quality of life, and more depression; comparisons between studies were hampered by the variety of tools and scoring scales used, however. No studies reported on economic outcomes. Conclusion: This REA indicates a substantial burden of osteoarthritis in weight-bearing joints in Africa and the Middle East, consistent with publications from other regions of the world. Keywords: Africa, burden of disease, Middle East, osteoarthritis, quality of life The weight-bearing joints of the knee and hip are commonly affected by degenerative changes leading to osteoarthritis (OA). The pathophysiologic processes involved in OA affect the whole joint and include synovial inflammation, degradation of cartilage, remodeling of bone, and formation of osteophytes; this results in symptoms of pain, stiffness, and impaired joint function. 1,2 Additionally, newer evidence suggests association of OA and low-grade intestinal inflammation. The studies also elude that alteration of the gut microbiota and impairment of the epithelial barrier can be related to mechanisms responsible for OA. 3 Patients with OA therefore often have reduced health-related quality of life, and chronic OA may lead to long-term disability and the need for joint replacement. 1 The 2019 American College of Rheumatology (ACR) Guidelines for the management of OA have made strong recommendations for including following non-pharmacological approaches: exercise, weight management, tai chi, cane use, self-efficacy and self-management programs, hand orthoses for first carpometacarpal (CMC) joint OA, tibiofemoral bracing for tibiofemoral knee OA. The guidelines recommend use of topical nonsteroidal anti-inflammatory drugs (NSAIDs) for knee OA, oral NSAIDs, and intraarticular glucocorticoid injections (knee OA) as a part of pharmacological approach. 2 Additional studies have supported use of manual therapy for symptomatic improvement of pain and for reducing the temporal summation in older adults. 4 A randomized controlled study by Romero et al explored use of dry needling in conjunction with exercise to reduce pain associated with knee OA, and further studies to assess its clinical effectiveness can be devised. 5 Patient education helps in managing pain and improving functionality in elderly OA patients. 6 The incidence and prevalence of radiographic and symptomatic OA typically increase with increasing age. 1,7 In general, wo -Abstract Truncated-